About Biomedical Materials
The goal of the journal is to publish original research findings and critical reviews that contribute to our knowledge about the composition, properties, and performance of materials for all applications relevant to human healthcare.
Typical areas of interest include (but are not limited to):
- Synthesis/characterization of biomedical materials
- Nature-inspired synthesis/biomineralization of biomedical materials
- In vitro/in vivo performance of biomedical materials
- Biofabrication technologies/applications: 3D bioprinting, bioink development, bioassembly & biopatterning
- Microfluidic systems (including disease models): fabrication, testing & translational applications
- Tissue engineering/regenerative medicine
- Interaction of molecules/cells with materials
- Effects of biomaterials on stem cell behaviour
- Growth factors/genes/cells incorporated into biomedical materials
- Biophysical cues/biocompatibility pathways in biomedical materials performance
- Clinical applications of biomedical materials for cell therapies in disease (cancer etc)
- Nanomedicine, nanotoxicology and nanopathology
- Pharmacokinetic considerations in drug delivery systems
- Risks of contrast media in imaging systems
- Biosafety aspects of gene delivery agents
- Preclinical and clinical performance of implantable biomedical materials
- Translational and regulatory matters
Why publish in Biomedical Materials?
- High standards: impartial, constructive and rigorous peer review.
- Fast publication: we are committed to providing you with a speedy, professional service to ensure rapid first decision, acceptance and publication. Once accepted, your article will be accessible to readers within 24 hours and will include a citable DOI.
- Full compliance with NIH Public Access Policy: we upload NIH-funded papers to PubMed Central on behalf of authors.
- Open access.
- Transfer opportunities: as well as accepting direct submissions, the journal also offers you a quick and easy solution to transfer your manuscript from another IOP Publishing journal if it does not fit that journal’s scope or significance criteria. Articles are transferred along with peer review reports to save time and avoid duplication of work for reviewers.
- Society owned: IOP Publishing is a leading society publisher of advanced physics research. Any profits generated by IOP Publishing are invested in the Institute of Physics, helping to support research, education and outreach around the world.
Biomedical Materials™ welcomes submissions of the following article types:
- Papers: descriptions of original scientific research, techniques and applications; not normally more than 12 000 words (14 journal pages). All research papers should show strong evidence validating the scientific hypothesis, or the novelty, performance or comparative advantage of the technique or application.
- Notes: shorter versions of Papers and not normally more than 4000 words (four journal pages).
- Topical Reviews: intended to summarize accepted practice and report on recent progress in selected areas; generally commissioned by the Editorial Board, from experts in various fields.
- Comments and Replies: comments on, or criticisms of, previously published work; not normally more than 1800 words (two journal pages).
Authors of all articles are required upon submission to disclose any potential conflict of interest (e.g. employment, consulting fees, industrial research contracts, stock ownership, equity interests, patent-licensing arrangements, honoraria, etc) in their covering letter. If the article is subsequently accepted for publication, this information should be included in an acknowledgments section.
Authors should also note that the journal fully endorses the principles embodied in the Declaration of Helsinki. All investigations involving humans must be conducted in accordance with these principles and in accordance with local statutory requirements. Articles relying on clinical trials should quote the trial registration number at the end of the abstract.
We also encourage the registration of such studies in a public trials registry prior to publication of the results in the journal. All investigations involving animal experimentation must be conducted in conformity with the ‘Guiding Principles for Research Involving Animals and Human Beings’ as adopted by The American Physiological Society.
The following summary describes the peer review process for Biomedical Materials, using the ANSI/NISO Standard Terminology for Peer Review:
- Identity transparency: single-anonymous, double-anonymous (author choice)
- Reviewer interacts with: Editor
- Review information published: review reports (author and reviewer opt in), author/editor communication, reviewer identities (reviewer opt in)
Our Publishing Support website provides more information on our reviewing process as well as checklists in both English and Chinese language to help authors prepare their manuscripts for submission.
If an article is not accepted for publication, we may offer the author the opportunity to transfer their submission to other suitable journals we publish.
Inclusivity and diversity
IOP Publishing recognises that there are inequalities within the scientific publishing and research ecosystems. We are committed to a progressive approach to inclusivity and diversity, and are working hard to eliminate discrimination to foster an equitable and welcoming publishing environment for all.
IOP Publishing follows Guidelines on Inclusive Language and Images in Scholarly Communication to ensure that journal articles use bias-free and culturally sensitive communication. We ask authors to please follow these guidelines in their manuscript submissions.
More information about our work on inclusivity is available on our Open Physics hub.
Please note that this policy requires authors to include a data availability statement in their article.
For any questions about the policy please contact the journal.
Many research funders now require authors to make all data related to their research available in an online repository. Please refer to the policy for further information about research data, data repositories and data citation.
Alternatively authors who do not select the gold open access option can choose a green open access route to publication.
Publication on a subscription-access basis is free of charge.
|Article publication charge*
|Reduced article publication charge* for Group B countries**
|Reduced article publication charge for Group A countries**
*excluding VAT where applicable
**eligibility criteria can be found here
APCs only apply to articles accepted for publication; there are no submission charges.
There are no other charges for publishing in Biomedical Materials.
Transformative AgreementsBiomedical Materials is included in our transformative agreements which allow authors from some institutions to publish open access without paying an APC.
If you are covered by an agreement, use our author guide to help you submit your paper.
Countries where we have transformative agreements include:
Austria, Canada, Croatia, Finland, Hungary, Ireland, Israel, Germany, Poland, The Netherlands, United Kingdom, Saudi Arabia, Slovenia, Sweden and Switzerland.
Paying for open access
Various discounts, waivers and funding arrangements are available to support our authors. Visit our Paying for open access page for further details.
Abstracting and indexing services
We work with our authors to help make their work as easy to discover as possible. Biomedical Materials is currently included in the following abstracting and discovery services:
- ISI (SciSearch®, Science Citation Index®, Materials Science Citation Index®, Journal Citation Reports/Science Edition, ISI Alerting Services)
- Aerospace & High Technology Database
- Chemical Abstracts Service
- Current Awareness in Biological Sciences
- INIS (International Nuclear Information System)
- NASA Astrophysics Data System
- VINITI Abstracts Journal (Referativnyi Zhurnal)